The treatment of Benign Paroxysmal Positional Vertigo & Tooth Sensitivity with vitamins

Benign Paroxysmal Positional Vertigo and Tooth Sensitivity: Mitamins custom make quality formulas for the treatment of Benign Paroxysmal Positional Vertigo & Tooth Sensitivity with vitamins. A Benign Paroxysmal Positional Vertigo & Tooth Sensitivity formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Benign Paroxysmal Positional Vertigo and Tooth Sensitivity

  • Amount Per Serving
    % DV
    Vitamin C
    500
    mg
    833%
    Vitamin D
    400
    IU
    100%
    Vitamin E
    400
    IU
    1333%
    Thiamin
    200
    mg
    13333%
    Riboflavin
    100
    mg
    5882%
    Niacin
    100
    mg
    500%
    Vitamin B6
    100
    mg
    5000%
    Folate
    400
    mcg
    100%
    Vitamin B12
    100
    mcg
    1667%
  • Amount Per Serving
    % DV
    Biotin
    100
    mcg
    33%
    Pantothenic Acid
    100
    mg
    1000%
    Calcium
    600
    mg
    60%
    Choline Bitartrate
    100
    mg
    *
    Inositol
    100
    mg
    *
    PABA
    100
    mg
    *
    Ginkgo Extract
    120
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Benign Paroxysmal Positional Vertigo and Tooth Sensitivity
Serving Size:4-5

Benign Paroxysmal Positional Vertigo and Tooth Sensitivity Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
FDA Approves RISPERDAL(R) To Treat Adolescents With Schizophrenia And Children And Adolescents With Bipolar Mania
The U.S. Food and Drug Administration (FDA) today approved RISPERDAL(R) (risperidone) for the treatment of schizophrenia in adolescents ages 13-17 and for the short-term treatment of bipolar mania associated with manic or mixed episodes of bipolar I disorder in children and adolescents ages 10-17.
Burden Of Care Rivals Complications Of Disease For Some Diabetics
Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.
This information concerning the support of Benign Paroxysmal Positional Vertigo and Tooth Sensitivity treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments